What the next 50 years of reproductive rights activism can learn from the last 50
By Felicia Kornbluh,
The Washington Post
| 01. 20. 2023
In June 1973, the Southern Poverty Law Center began publicizing a case it was pursuing in defense of two Black children from Alabama, Minnie Lee and Mary Alice Relf. The Relf sisters, 14 and 12 years old, had been sterilized on the recommendation of a nurse employed by the federal government. The girls’ mother, who reportedly could not read or write, signed consent forms for the sterilization of her two young daughters with an “X” and said later that she thought she was authorizing a form of reversible birth control, not a permanent removal of her daughters’ reproductive capacity. Relf v. Weinberger burst onto the scene just six months after Supreme Court Justice Harry A. Blackmun published his opinion for the majority in Roe v. Wade on Jan. 22, 1973, 50 years ago this week. This was a time of celebration for most feminists, and justly so: Their movement, working ardently at the grass roots and uniting across many lines of difference, had persuaded the nation’s highest court to recognize people’s need to make autonomous choices about whether to end...
Related Articles
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...